Edgar L. Frazell
New York State Department of Health
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Edgar L. Frazell.
American Journal of Surgery | 1968
Harold E. Ramsey; Elliot W. Strong; Edgar L. Frazell
Abstract In this series of forty-seven patients with fibrous dysplasia of the craniofacial bones the disease was generally monostotic and most commonly mandibular in location. No patients demonstrated any endocrine, developmental, or congenital anomalies. The universal finding was the presence of a bony mass. Marked deformity, pain, or functional disturbance were the major indications for treatment. Total excision of the involved bone was the most successful form of treatment but produced the greatest functional and cosmetic deficits. Not all patients required treatment once the diagnosis was confirmed. No instances of malignant degeneration were noted and only one death from very aggressive disease was recorded. A conservative therapeutic approach appears indicated and modest reduction in the bulk of these lesions may be sufficient to effectively relieve signs and symptoms. Periodic follow-up evaluation is indicated to detect recurrence or, more remotely, malignant change in its early stages.
American Journal of Surgery | 1965
Robert V. P. Hutter; H.Randall Tollefsen; Jerome J. De Cosse; Frank W. Foote; Edgar L. Frazell
Abstract The preceding discussion serves to re-emphasize that metaplasia to a highly lethal form of thyroid cancer can occur in the usually indolent papillary thyroid cancer. When this happens, these patients usually have the ominous signs previously elucidated. There is recent rapid growth in the thyroid or neck nodes, a large (over 5 cm.) tumor, and recurrent laryngeal nerve palsy. However, these signs are not always present. Furthermore, metaplasia may not be manifest in the first material examined histologically. There may be a long interval from the initial treatment to the appearance of large areas of metaplasia (twelve and ten years in two of these cases). Metaplasia may be present in either or both the primary tumor, cervical, or other metastases. Its absence in the primary lesion does not preclude its appearance in subsequent metastases. This was demonstrated in two patients in this review. There was metaplasia in a submental node in one (case IV) and an axillary node in the other (case V) with no evidence of metaplasia in the primary lesion in either. Once spindle or giant cell metaplasia is evident in large amounts, the prognosis is grave; the average time until death is five months.
Cancer | 1953
Frank W. Foote; Edgar L. Frazell
Cancer | 1958
Edgar L. Frazell; Frank W. Foote
American Journal of Surgery | 1969
Alan D. Turnbull; Edgar L. Frazell
Cancer | 1955
Edgar L. Frazell; Frank W. Foote
The Journal of Clinical Endocrinology and Metabolism | 1949
Edgar L. Frazell; Frank W. Foote
Cancer | 1951
Edgar L. Frazell; Benedict J. Duffy
Cancer | 1948
Paul Wozencraft; Frank W. Foote; Edgar L. Frazell
American Journal of Surgery | 1968
Ronald H. Spiro; Edgar L. Frazell